PASQUALONE FRANK
SEC CIK 1597334 · EDGAR
BoughtSold
Most active insiders at ENVB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeWitt Sheila | Dir | — | — |
| 2 | Coveney Kevin Michael | CFO | — | — |
| 3 | Facchini Peter J. | Chief Innovation Off | — | — |
| 4 | Tucker Joseph Edward | CEO, Dir | — | — |
| 5 | Kegler George A. | Dir | — | — |
| 6 | Schabacker Marcus | Dir | — | — |
| 7 | PASQUALONE FRANK | Dir | — | — |
| 8 | WEBB MICHAEL D | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 16:30 | 2026-06-01 | ENVB | Enveric Biosciences, Inc. | PASQUALONE FRANK | Dir | A - Grant | $0.00 | +18.5K | 26.4K | +234% | $0 | |
| 2025-12-30 | 2025-12-23 | ENVB | Enveric Biosciences, Inc. | PASQUALONE FRANK | Dir | A - Grant | $0.00 | +7,633 | 7,904 | +2,817% | $0 | |
| 2024-10-11 | 2024-10-09 | ENVB | Enveric Biosciences, Inc. | PASQUALONE FRANK | Dir | A - Grant | $0.00 | +47.7K | 48.7K | +4,773% | $0 | |
| 2023-09-19 | 2023-09-15 | ENVB | Enveric Biosciences, Inc. | PASQUALONE FRANK | Dir | P - Purchase | $2.14 | +1,000 | 1,000 | New | +$2,140 | |
| 2021-11-23 | 2021-11-19 | TBPH | Theravance Biopharma, Inc. | PASQUALONE FRANK | SVP, Chief BUSINESS Off | F - Tax | $8.36 | -3,779 | 429.8K | -0.9% | -$31.6K | |
| 2021-08-24 | 2021-08-20 | TBPH | Theravance Biopharma, Inc. | PASQUALONE FRANK | SVP, Chief Business Off | F - Tax | $14.05 | -3,779 | 433.6K | -0.9% | -$53.1K |
Purchase Sale Sale after option exercise All abbreviations